"This study provides strong evidence for the use of daratumumab as a treatment for high-risk smoldering multiple myeloma," says Dr. Rajkumar, the Edward W. and Betty Knight Scripps Professor of ...

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition ...

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk ...

Myeloma is most common in people over 60 and is characterized by the accumulation of abnormal plasma cells in the bone marrow, which impairs the normal production of blood cells.

More than one bone lesion of at least 5 millimeters or bigger on an MRI. The abnormal plasma cells in your bone marrow can cause damaged and weak spots in your bones. As a result, calcium from ...

Amyloidosis is caused by cancerous plasma cells in the bone marrow leading to an abnormal buildup of a protein called amyloid in organs and tissues throughout the body. The body doesn’t have an ...

that resulted from multiple myeloma (a blood cancer that occurs when abnormal plasma cells build up in the bone marrow). The autologous stem cell transplant (ASCT) helped Baban Pandurang Shinde to ...